Dow Closes At Record On News Of Second Potential COVID-19 Vaccine
By VOA
The U.S. Dow Jones Industrial Average closed at a record high Monday as investors embraced news of another breakthrough in the effort to develop an effective COVID-19 vaccine to attack the global coronavirus pandemic.
The bellwether Dow Jones Industrial Average of 30 key U.S. stocks erased the last of its pandemic losses Monday, rising 1.6% to close at 29,950, just shy of the 30,000 mark.
The broader S&P 500 added to the record high it reached last Friday, gaining nearly 1.2%, while the tech-heavy Nasdaq composite rose 0.8%.
European indexes also advanced on the news from U.S.-based drugmaker Moderna that its experimental coronavirus vaccine is nearly 95% effective, based on preliminary data from its late-stage clinical trial.
The Moderna vaccine is the second such potential vaccine to show favorable results, following a joint initiative by U.S.-based Pfizer and Germany-based BioNTech announced last week. The coronavirus causes the COVID-19 disease.
Britain’s benchmark FTSE index closed up 1.7%, the same as the CAC-40 in France. Germany’s DAX index ended up a half percentage point.
Markets in the Asia-Pacific rim began the week with a strong start earlier Monday following good economic news from Japan and China.
Japan’s benchmark Nikkei index closed just more than 2% higher. Hong Kong’s Hang Seng was up 0.8%, while the Shanghai composite index gained 1.1%. Australia’s S&P/ASX index gained 1.2%. The KOSPI index finished 1.9% higher, and Taiwan’s TSEC was up 2.1%.
Japan’s government announced Monday that the world’s third-largest economy grew at an annual pace of 21% in the third quarter spanning from July to September, while Beijing announced that its factory output rose a better-than-expected 6.9% in October compared with a year earlier.
In commodities trading, gold rose $1.60 to sell at $1,887.80 an ounce. U.S. crude oil rose $1.21 to sell at $41.34 per barrel, and Brent crude rose $1.04 to sell at $43.82 a barrel.
